Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by MARY ESTES and SASIREKHA RAMANI.
MARY ESTES
Connection Strength
9.581
SASIREKHA RAMANI
  1. Human milk oligosaccharides, milk microbiome and infant gut microbiome modulate neonatal rotavirus infection. Nat Commun. 2018 11 27; 9(1):5010.
    View in: PubMed
    Score: 0.648
  2. Human organoid cultures: transformative new tools for human virus studies. Curr Opin Virol. 2018 04; 29:79-86.
    View in: PubMed
    Score: 0.620
  3. Diversity in Rotavirus-Host Glycan Interactions: A "Sweet" Spectrum. Cell Mol Gastroenterol Hepatol. 2016 May; 2(3):263-273.
    View in: PubMed
    Score: 0.537
  4. Epidemiology of human noroviruses and updates on vaccine development. Curr Opin Gastroenterol. 2014 Jan; 30(1):25-33.
    View in: PubMed
    Score: 0.461
  5. The VP8* domain of neonatal rotavirus strain G10P[11] binds to type II precursor glycans. J Virol. 2013 Jul; 87(13):7255-64.
    View in: PubMed
    Score: 0.440
  6. Norovirus replication, host interactions and vaccine advances. Nat Rev Microbiol. 2025 Jan 17.
    View in: PubMed
    Score: 0.248
  7. 2'-Fucosyllactose inhibits human norovirus replication in human intestinal enteroids. J Virol. 2025 Jan 10; e0093824.
    View in: PubMed
    Score: 0.248
  8. Correlation of Genogroup I, Genotype 1 (GI.1) Norovirus Neutralizing Antibody Levels With GI.1 Histo-Blood Group Antigen-Blocking Antibody Levels. J Infect Dis. 2024 Dec 16; 230(6):1376-1379.
    View in: PubMed
    Score: 0.246
  9. Lack of Detection of Norwalk Virus in Saliva Samples From a Controlled Human Infection Model. Open Forum Infect Dis. 2024 Nov; 11(11):ofae652.
    View in: PubMed
    Score: 0.244
  10. Insights into human norovirus cultivation in human intestinal enteroids. mSphere. 2024 Nov 21; 9(11):e0044824.
    View in: PubMed
    Score: 0.243
  11. INTRA- AND INTER-HOST EVOLUTION OF HUMAN NOROVIRUS IN HEALTHY ADULTS. bioRxiv. 2024 Sep 05.
    View in: PubMed
    Score: 0.242
  12. Infant and adult human intestinal enteroids are morphologically and functionally distinct. mBio. 2024 Aug 14; 15(8):e0131624.
    View in: PubMed
    Score: 0.239
  13. Divergent responses of human intestinal organoid monolayers using commercial in vitro cytotoxicity assays. PLoS One. 2024; 19(6):e0304526.
    View in: PubMed
    Score: 0.238
  14. 2'-Fucosyllactose Inhibits Human Norovirus Replication in Human Intestinal Enteroids. bioRxiv. 2024 May 30.
    View in: PubMed
    Score: 0.237
  15. A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies. J Infect Dis. 2024 May 15; 229(5):1402-1407.
    View in: PubMed
    Score: 0.237
  16. Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activity. Antimicrob Agents Chemother. 2023 10 18; 67(10):e0063623.
    View in: PubMed
    Score: 0.227
  17. A Standardized Antiviral Pipeline for Human Norovirus in Human Intestinal Enteroids Demonstrates No Antiviral Activity of Nitazoxanide. bioRxiv. 2023 May 23.
    View in: PubMed
    Score: 0.221
  18. Organoids to Dissect Gastrointestinal Virus-Host Interactions: What Have We Learned? Viruses. 2021 05 27; 13(6).
    View in: PubMed
    Score: 0.193
  19. New Insights and Enhanced Human Norovirus Cultivation in Human Intestinal Enteroids. mSphere. 2021 01 27; 6(1).
    View in: PubMed
    Score: 0.188
  20. Human norovirus exhibits strain-specific sensitivity to host interferon pathways in human intestinal enteroids. Proc Natl Acad Sci U S A. 2020 09 22; 117(38):23782-23793.
    View in: PubMed
    Score: 0.183
  21. Comparison of Microneutralization and Histo-Blood Group Antigen-Blocking Assays for Functional Norovirus Antibody Detection. J Infect Dis. 2020 02 18; 221(5):739-743.
    View in: PubMed
    Score: 0.176
  22. Bile acids and ceramide overcome the entry restriction for GII.3 human norovirus replication in human intestinal enteroids. Proc Natl Acad Sci U S A. 2020 01 21; 117(3):1700-1710.
    View in: PubMed
    Score: 0.175
  23. Establishing Human Intestinal Enteroid/Organoid Lines from Preterm Infant and Adult Tissue. Methods Mol Biol. 2020; 2121:185-198.
    View in: PubMed
    Score: 0.175
  24. Human Norovirus Cultivation in Nontransformed Stem Cell-Derived Human Intestinal Enteroid Cultures: Success and Challenges. Viruses. 2019 07 11; 11(7).
    View in: PubMed
    Score: 0.169
  25. Human Intestinal Enteroids: New Models to Study Gastrointestinal Virus Infections. Methods Mol Biol. 2019; 1576:229-247.
    View in: PubMed
    Score: 0.163
  26. Human noroviruses: recent advances in a 50-year history. Curr Opin Infect Dis. 2018 10; 31(5):422-432.
    View in: PubMed
    Score: 0.160
  27. Engineered Human Gastrointestinal Cultures to Study the Microbiome and Infectious Diseases. Cell Mol Gastroenterol Hepatol. 2018 Mar; 5(3):241-251.
    View in: PubMed
    Score: 0.151
  28. Milk Oligosaccharides Inhibit Human Rotavirus Infectivity in MA104 Cells. J Nutr. 2017 09; 147(9):1709-1714.
    View in: PubMed
    Score: 0.147
  29. B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine. Clin Vaccine Immunol. 2017 May; 24(5).
    View in: PubMed
    Score: 0.145
  30. Rotavirus Serum IgA Immune Response in Children Receiving Rotarix Coadministered With bOPV or IPV. Pediatr Infect Dis J. 2016 10; 35(10):1137-9.
    View in: PubMed
    Score: 0.139
  31. Replication of human noroviruses in stem cell-derived human enteroids. Science. 2016 09 23; 353(6306):1387-1393.
    View in: PubMed
    Score: 0.139
  32. Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go? PLoS Pathog. 2016 04; 12(4):e1005334.
    View in: PubMed
    Score: 0.135
  33. Mucosal and Cellular Immune Responses to Norwalk Virus. J Infect Dis. 2015 Aug 01; 212(3):397-405.
    View in: PubMed
    Score: 0.124
  34. Structural basis of glycan interaction in gastroenteric viral pathogens. Curr Opin Virol. 2014 Aug; 7:119-27.
    View in: PubMed
    Score: 0.120
  35. Structural characterization by multistage mass spectrometry (MSn) of human milk glycans recognized by human rotaviruses. Mol Cell Proteomics. 2014 Nov; 13(11):2961-74.
    View in: PubMed
    Score: 0.120
  36. A time-resolved immunoassay to measure serum antibodies to the rotavirus VP6 capsid protein. J Virol Methods. 2013 Apr; 189(1):228-31.
    View in: PubMed
    Score: 0.107
  37. Geographic information systems and genotyping in identification of rotavirus G12 infections in residents of an urban slum with subsequent detection in hospitalized children: emergence of G12 genotype in South India. J Clin Microbiol. 2007 Feb; 45(2):432-7.
    View in: PubMed
    Score: 0.071
  38. Conformational flexibility is a critical factor in designing broad-spectrum human norovirus protease inhibitors. J Virol. 2025 Jan 28; e0175724.
    View in: PubMed
    Score: 0.062
  39. CONFORMATIONAL FLEXIBILITY IS A CRITICAL FACTOR IN DESIGNING BROAD-SPECTRUM HUMAN NOROVIRUS PROTEASE INHIBITORS. bioRxiv. 2024 Sep 19.
    View in: PubMed
    Score: 0.061
  40. Insights into Human Norovirus Cultivation in Human Intestinal Enteroids. bioRxiv. 2024 Sep 19.
    View in: PubMed
    Score: 0.061
  41. Complete Genomic Characterization of Global Pathogens, Respiratory Syncytial Virus (RSV), and Human Norovirus (HuNoV) Using Probe-based Capture Enrichment. bioRxiv. 2024 Sep 16.
    View in: PubMed
    Score: 0.061
  42. Infant and Adult Human Intestinal Enteroids are Morphologically and Functionally Distinct. bioRxiv. 2024 Feb 17.
    View in: PubMed
    Score: 0.058
  43. Distinct gene expression profiles between human preterm-derived and adult-derived intestinal organoids exposed to Enterococcus faecalis: a pilot study. Gut. 2021 Dec 17.
    View in: PubMed
    Score: 0.050
  44. Norovirus Protease Structure and Antivirals Development. Viruses. 2021 10 14; 13(10).
    View in: PubMed
    Score: 0.049
  45. Glycan Recognition in Human Norovirus Infections. Viruses. 2021 10 14; 13(10).
    View in: PubMed
    Score: 0.049
  46. Drivers of transcriptional variance in human intestinal epithelial organoids. Physiol Genomics. 2021 11 01; 53(11):486-508.
    View in: PubMed
    Score: 0.049
  47. Norovirus in Cancer Patients: A Review. Open Forum Infect Dis. 2021 Jun; 8(6):ofab126.
    View in: PubMed
    Score: 0.047
  48. Genetic Manipulation of Human Intestinal Enteroids Demonstrates the Necessity of a Functional Fucosyltransferase 2 Gene for Secretor-Dependent Human Norovirus Infection. mBio. 2020 03 17; 11(2).
    View in: PubMed
    Score: 0.044
  49. Two- and Three-Dimensional Bioengineered Human Intestinal Tissue Models for Cryptosporidium. Methods Mol Biol. 2020; 2052:373-402.
    View in: PubMed
    Score: 0.044
  50. Glycan recognition in globally dominant human rotaviruses. Nat Commun. 2018 07 06; 9(1):2631.
    View in: PubMed
    Score: 0.039
  51. Rotavirus infection. Nat Rev Dis Primers. 2017 Nov 09; 3:17083.
    View in: PubMed
    Score: 0.038
  52. Prospects and Challenges in the Development of a Norovirus Vaccine. Clin Ther. 2017 Aug; 39(8):1537-1549.
    View in: PubMed
    Score: 0.037
  53. Structural features of glycan recognition among viral pathogens. Curr Opin Struct Biol. 2017 06; 44:211-218.
    View in: PubMed
    Score: 0.037
  54. Norovirus Gastroenteritis in a Birth Cohort in Southern India. PLoS One. 2016; 11(6):e0157007.
    View in: PubMed
    Score: 0.034
  55. Structural basis of glycan specificity in neonate-specific bovine-human reassortant rotavirus. Nat Commun. 2015 Sep 30; 6:8346.
    View in: PubMed
    Score: 0.033
  56. Human milk contains novel glycans that are potential decoy receptors for neonatal rotaviruses. Mol Cell Proteomics. 2014 Nov; 13(11):2944-60.
    View in: PubMed
    Score: 0.030
  57. Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med. 2014 Jan-Feb; 21(1):6-11.
    View in: PubMed
    Score: 0.029
  58. Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis. 2014 Apr 01; 209(7):1016-22.
    View in: PubMed
    Score: 0.029
  59. Exposure to human and bovine noroviruses in a birth cohort in southern India from 2002 to 2006. J Clin Microbiol. 2013 Jul; 51(7):2391-5.
    View in: PubMed
    Score: 0.027
  60. Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med. 2011 Jul 28; 365(4):337-46.
    View in: PubMed
    Score: 0.024
  61. Neonatal infection with G10P[11] rotavirus did not confer protection against subsequent rotavirus infection in a community cohort in Vellore, South India. J Infect Dis. 2007 Mar 01; 195(5):625-32.
    View in: PubMed
    Score: 0.018
  62. Comparative study of the epidemiology of rotavirus in children from a community-based birth cohort and a hospital in South India. J Clin Microbiol. 2006 Jul; 44(7):2468-74.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.